INVO Fertility, Inc. (Nasdaq: IVF) reported second-quarter 2026 revenue of $2.18 million, up 17% from $1.86 million a year earlier. Net income was $888,740, compared with a net loss of $3.62 million in the prior-year quarter.
The company said the quarter included a $2.45 million gain on remeasurement related to its Birmingham clinic acquisition. Family Beginnings contributed for a full quarter following its February 2026 acquisition.
- Total revenue was $2,175,485 for the quarter ended June 30, 2026.
- Clinic revenue rose 18% to $2,167,785.
- Basic earnings per share were $0.42, while diluted earnings per share were $0.35.
- Loss from operations was $1.29 million.
- Cash totaled approximately $3.7 million as of June 30, 2026.
- Clinic-Level Adjusted EBITDA, a non-GAAP measure, was approximately $333,000.
$IVF Hedge Fund Activity
We have seen 9 institutional investors add shares of $IVF stock to their portfolio, and 9 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MARINER, LLC removed 100,000 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $190,000
- ARMISTICE CAPITAL, LLC removed 71,866 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $136,545
- VIRTU FINANCIAL LLC added 63,174 shares (+inf%) to their portfolio in Q2 2026, for an estimated $120,030
- SCIENTECH RESEARCH LLC added 32,338 shares (+inf%) to their portfolio in Q2 2026, for an estimated $61,442
- ADAR1 CAPITAL MANAGEMENT, LLC removed 26,722 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $72,683
- GEODE CAPITAL MANAGEMENT, LLC removed 16,848 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $32,011
- STONEX GROUP INC. added 15,702 shares (+inf%) to their portfolio in Q2 2026, for an estimated $29,833
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
